Prostate Specific Antigen, Enzymatically Active, Human Seminal Fluid

Native, enzymatically active prostate specific antigen from human seminal fluid. A single-chain glycoprotein with one asparagine-linked carbohydrate side chain. A preeminent clinical tumor marker in the management of patients with prostate cancer.

Biologically active as tested by its ability to hydrolyze the synthetic peptide substrate MeO-Suc-Arg-Pro-Tyr-pNA

Please refer to vial label for lot-specific concentration.

Toxicity: Standard Handling (A)

In 150 mM Sodium Chloride, 9.5 mM Sodium Phosphate Monobasic, 40.5 mM Sodium Phosphate Dibasic, 0.05% Sodium Azide, pH 7.6.

Prepared from fluids of individuals that have been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Following initial thaw, aliquot and freeze (-20°C).

Higashihara, E., et al. 1996. J. Urol.156, 1964.
Kablin, J.N. 1992. Geriatrics47, 23.
Stamey, T.A., et al. 1987. N. Engl. J. Med. 317, 909.
Papsidero, L.D., et al. 1980. Cancer Res.40, 2428.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany